<(N,N-dimethylamino)ethyl>isobutyrate | 116996-27-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: <(N,N-dimethylamino)ethyl>isobutyrate
• 英文别名: 2-Dimethylaminoethyl isobutyrate；2-(dimethylamino)ethyl 2-methylpropanoate
• CAS: 116996-27-1
• 化学式: C₈H₁₇NO₂
• 分子量: 159.228
• InChiKey: KGDZKJVWYDVPRA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  <(N,N-dimethylamino)ethyl>isobutyrate 、 Chloro-acetic acid (8S,9S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-1,13-dimethyl-9,11,12,13,14,15,16,17-octahydro-8H-cyclopenta[a]phenanthren-3-yl ester 反应 24.0h， 生成 <<<(1-methyl-1,3,5,6-norcholestatetraen-3-yl)oxy>carbonyl>methyl><2-(isobutyryloxy)ethyl>dimethylammonium chloride
  参考文献：
  名称：

  Highly enantioselective solvolyses of L- and D-phenylalanine p-nitrophenyl esters by an L-histidyl dipeptide in surfactant coaggregates formed by cholesterol-containing amphiphiles

  摘要：

  DOI：

  10.1021/jo00256a064
• 作为产物：
  描述：

  N,N-二甲基乙醇胺 、 三乙胺 、 异丁酰氯 、 碳酸氢钠 在 碳酸氢钠 、 Sodium sulfate-III 作用下， 以 1L 、 水 、 二氯甲烷 为溶剂， 反应 0.5h， 以to give 46.2 g of 2-dimethylaminoethyl isobutyrate, b.p. 59°-64° C. (8-10 mm)的产率得到<(N,N-dimethylamino)ethyl>isobutyrate
  参考文献：
  名称：

  Amine-containing block polymers for pigmented ink jet inks

  摘要：

  一种具有改进分散稳定性的水性喷墨墨水组合物，包括水性载体介质，具有低于7.0的pH值的颜料，以及由A块和B块组成的AB嵌段聚合物，其中A块包括至少具有一个碱性胺基官能团的疏水性聚合物，B块包括选自非离子聚合物和含有酸性官能团的聚合物的亲水性聚合物。

  公开号：

  US05272201A1

文献信息

• BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS
  申请人：ALNYLAM PHARMACEUTICALS, INC.

  公开号：US20160009637A1

  公开（公告）日：2016-01-14

  The present invention relates to a cationic lipid having one or more biodegradable groups located in the mid- or distal section of a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

  本发明涉及一种阳离子脂质，其具有位于脂质基团（例如，疏水链）的中部或远端部位的一个或多个可生物降解的基团。这些阳离子脂质可以被纳入脂质颗粒中，用于传递活性剂，例如核酸。该发明还涉及包括中性脂质、能够减少聚集的脂质、本发明的阳离子脂质以及可选地固醇的脂质颗粒。脂质颗粒还可以进一步包含治疗剂，如核酸。
• Papermaking chemical, method for manufacturing same, and paper containing same
  申请人：Kiyosada Toshitsugu

  公开号：US20050272889A1

  公开（公告）日：2005-12-08

  A novel (meth)acrylamide polymer capable of forming a papermaking chemical exhibiting an excellent paper strengthening effect, drainage improvement effect, retention improvement effect, plybond strength enhancing effect, surface strength enhancing effect, and sizing improvement effect in acid, neutral, or alkaline papermaking systems, as well as a method for manufacturing this polymer, and paper that makes use of this polymer and has excellent bursting strength, internal bond strength, and other such properties is provided. This is a (meth)acrylamide polymer produced by polymerizing a monomer (a) expressed by the following general formula 1, the following monomer (b), and the following monomer (c): (a) general formula 1: (b) a (meth)acrylamide; (c) an ionic monomer other than monomer (a) expressed by general formula 1 above

  提供了一种新型（甲基）丙烯酰胺聚合物，能够形成一种造纸化学品，具有优异的造纸强化效果、排水改善效果、保留改善效果、层压强度增强效果、表面强度增强效果和尺寸稳定性改善效果，适用于酸性、中性或碱性造纸系统，以及制造该聚合物的方法和使用该聚合物的纸张，具有优异的爆裂强度、内部粘合强度和其他类似性能。该聚合物是通过聚合以下通式1所表示的单体（a）、以下单体（b）和以下单体（c）制备的：（a）通式1：（b）（甲基）丙烯酰胺；（c）除通式1所述的单体（a）之外的离子单体。
• Chain transfer agents for raft polymerization in aqueous media
  申请人：McCormick L. Charles

  公开号：US20070123670A1

  公开（公告）日：2007-05-31

  Polymers and copolymers synthesized by means that yield a narrow range of molecular weights can have different properties than polymers synthesized by conventional means. In order to obtain such polymers, however, polymerization must be controlled. One type of controlled polymerization is the reversible addition-fragmentation chain transfer (RAFT) process, which has characteristics of a living polymerization. The present invention discloses a group of dithioesters and trithioesters suitable as chain transfer agents for RAFT polymerization. The present invention also discloses RAFT polymerizations conducted in aqueous media.

  通过产生分子量窄范围的手段合成的聚合物和共聚物可能具有不同于传统手段合成的聚合物的性质。然而，为了获得这种聚合物，聚合必须受到控制。一种受控聚合的类型是可逆加成-断裂链转移（RAFT）过程，具有活性聚合的特征。本发明揭示了一组二硫代酯和三硫代酯，适用于RAFT聚合的链转移剂。本发明还揭示了在水介质中进行的RAFT聚合。
• MACROCYCLES AS FACTOR XIA INHIBITORS
  申请人：Corte James R.

  公开号：US20120041190A1

  公开（公告）日：2012-02-16

  The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.

  本发明提供了式(I)的化合物：或其立体异构体、互变异构体或药学上可接受的盐，其中所有变量如此定义。这些化合物是选择性因子XIa抑制剂或fXIa和血浆卡利肌酶的双重抑制剂。本发明还涉及包含这些化合物的制药组合物以及使用它们治疗血栓栓塞和/或炎症性疾病的方法。
• Branched Alkyl And Cycloalkyl Terminated Biodegradable Lipids For The Delivery Of Active Agents
  申请人：ALNYLAM PHARMACEUTICALS, INC.

  公开号：US20150005363A1

  公开（公告）日：2015-01-01

  The present invention relates to a cationic lipid of formula (I) having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

  本发明涉及一种具有公式（I）的阳离子脂质，其中在脂质部分（例如，疏水链）中具有一个或多个可生物降解的基团。这些阳离子脂质可以被纳入到脂质粒中，以传递活性剂，例如核酸。本发明还涉及包括中性脂质、能够减少聚集的脂质、本发明中的阳离子脂质以及可选的固醇的脂质粒。该脂质粒还可以包括治疗剂，例如核酸。